Deborah R Flomenhoft MD
Inflammatory Bowel Disease, Malabsorption, Nutrition
Associate Professor of Internal Medicine University KY College of Medicine
740 Rose StLexington, KY 40536
Fax+1 859-257-8675
Overview of Dr. Flomenhoft
Deborah Flomenhoft, MD, is a gastroenterologist based in Lexington, KY, with a sub-specialization in Advanced Endoscopic Interventional and Inflammatory Bowel Disease. She completed her residency in Internal Medicine/Pediatrics at the University of Kentucky College of Medicine in 2002, where she also graduated from. Dr. Flomenhoft has an extensive research profile in her field, with numerous publications on inflammatory bowel disease and colorectal cancer in reputable journals, and the studies have been cited multiple times. Her clinical trials include a study on Methotrexate in the induction and maintenance of steroid-free remission in Ulcerative Colitis.
Education & Training
University of Kentucky College of MedicineResidency, Internal Medicine/Pediatrics, 1998 - 2002
University of Kentucky College of MedicineClass of 1998
Certifications & Licensure
KY State Medical License 1999 - 2027
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2015-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2015-2017
Clinical Trials
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- Implementation and assessment of a postreprocessing endoscope surveillance program at the University of Kentucky, 2019-2024.Court Desmond, Faith Fursman, Derek Forster, Julie A Ribes, Sandra L Mills
Infection Control and Hospital Epidemiology. 2026-04-14 - 3 citationsDual Biologic Therapy Induces Remission in Refractory Crohn's Disease With Vedolizumab and Ustekinumab.Syed Adeel Hassan, Courtney Perry, Patrick Carey, Durham Colohan, Mohamed Gebril Eltaher
Crohn's & Colitis 360. 2025-01-01 - Sevelamer-Induced Ischemic Enteritis.Hannah Darnell, Aaron Brenner, Cody Kern, Deborah Flomenhoft, Eun Lee
ACG Case Reports Journal. 2024-07-01
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Multiplan PPO
Premera BCBS Heritage & Heritage Plus 1
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
